Abbvie Biotechnology competitive analysis

Explore Abbvie Biotechnology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 18, 2017Methods Of Administering Anti-Tnfalpha Antibodies11
Nov 2, 2016Multiple-Variable Dose Regimen For Treating Tnfalpha-Related Disorders11
Sep 21, 2016Improved High Concentration Anti-Tnfalpha Antibody Liquid Formulations4
Mar 11, 2015Treatment Of Tnf Alpha Related Disorders13
Jan 14, 2015Method Of Treating Depression Using A Tnf-Alpha Antibody2

Latest PTAB cases involving Abbvie Biotechnology

Discover the latest PTAB cases involving Abbvie Biotechnology, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 14, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Abbvie Biotechnology

IPR2018-00156Nov 6, 2017SANDOZABBVIE BIOTECHNOLOGYInstitution Denied
IPR2018-00002Oct 2, 2017SANDOZABBVIE BIOTECHNOLOGYInstitution Denied
IPR2017-02105Sep 14, 2017SANDOZABBVIE BIOTECHNOLOGYTerminated-Settled
IPR2017-02106Sep 14, 2017SANDOZABBVIE BIOTECHNOLOGYTerminated-Settled
IPR2017-01987Aug 21, 2017SANDOZABBVIE BIOTECHNOLOGYInstitution Denied
IPR2017-01988Aug 21, 2017SANDOZABBVIE BIOTECHNOLOGYInstitution Denied
IPR2017-01823Jul 20, 2017SANDOZABBVIE BIOTECHNOLOGYInstitution Denied
IPR2017-01824Jul 20, 2017SANDOZABBVIE BIOTECHNOLOGYInstitution Denied
IPR2017-01008Mar 2, 2017COHERUS BIOSCIENCESABBVIE BIOTECHNOLOGYInstitution Denied
IPR2017-01009Mar 2, 2017COHERUS BIOSCIENCESABBVIE BIOTECHNOLOGYInstitution Denied

Peer Comparison New

IP litigation analysis comparing Abbvie Biotechnology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ABBVIE BIOTECHNOLOGY - 41 - 22
AMGEN14163811
COHERUS BIOSCIENCES - - 121
SANDOZ1492619 -